Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
C2 Pharma
CAI
DPS Group
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Biopharmaceutical
24 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Miniaturized Mass Spectrometry
Bringing Mass Spectrometry out of the Lab and to the Point of Need
PAO-09-022-CL-10
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
PR-M09-22-01
New Biodefense Facility
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
PR-M04-22-12
Social Media Marketing
Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?
Biopharmaceutical Manufacturing
Bridging the Biopharmaceutical Manufacturing Digital Divide
PAO-03-21-CL-04
Industry Leader
Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing
PAP-Q4-20-CL-023
Glocalization
Impacts of Glocalization on the Pharmaceutical Industry
PAP-Q3-19-NI-001
Supply Chain Solutions
Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma
PAP-Q1-2019-CL-008
Contract Manufacturing Needs
Meeting Biopharma Contract Manufacturing Needs with a Flexible Global Network
PAP-Q2-18-CL-006
Business
PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors
PR-M01-18-NI-007
Innovation
The New Wave In Cancer Screening: Liquid Biopsy Testing
APR-M04-17-NI-001
Biopharmaceutical
Abzena on the Road to BIO: Fueling Biopharmaceutical Development
PTV-M06-17-CL-006
Innovation
Designing Flexibility for Added Value
PAP-Q2-17-CL-015
Merck and Bristol-Myers Squibb Extend Partnerships with Incyte
PAO-M04-17-NI-005
Investment in Biopharma Facilities Continues
PMO-M11-16-NI-001
Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience
PAP-Q03-16-CL-005
Pharma Equipment Budget Expansion Fueling Quest For Operational Excellence
APR-M06-16-NI-001
Controlling Glycosylation for Improved Product Quality
BIO-M06-16-NI-001
Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals
PAP-Q02-16-CL-011
Achieving Large-Scale Cell and Gene Therapy Manufacturing
PAP-Q02-16-CL-010
Bolstering Capabilities for Parenteral Drug Development and Manufacturing
PAP-Q4-15-CL-005
A Look At 2015 Outsourcing Trends And What To Expect In 2016
LSL-M10-15-NI-001
Manufacturers and CMOs Streamline Bioprocessing with Single-Use Devices
POP-M09-15-NI-001
Four Keys to Successful Biopharmaceutical Outsourcing: Technical Expertise, Quality, Reliability and Timeliness
PAP-APR-S01-CL-001
